Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study

INTRODUCTION: Dolutegravir (DTG), Elvitegravir (EVG), Raltegravir (RAL) and Darunavir (DRV) are commonly prescribed core agents for antiretroviral therapy (ART), and a need exists to compare their clinical effectiveness, as defined by virologic failure risks in real-world settings. METHODS: This obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Anthony M., Brunet, Laurence, Fusco, Jennifer S., Wohlfeiler, Michael B., Garris, Cindy P., Oglesby, Alan K., Mrus, Joseph M., Lackey, Philip C., Fusco, Gregory P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054577/
https://www.ncbi.nlm.nih.gov/pubmed/31701370
http://dx.doi.org/10.1007/s40121-019-00274-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054577/
https://www.ncbi.nlm.nih.gov/pubmed/31701370
http://dx.doi.org/10.1007/s40121-019-00274-5

Ejemplares similares